MedPath

Comparative Clinical Study of 2 Drug Vatnashini Vati and Rasnadi Guggul in the treatment of Gridhrasi W.S.R. to Sciatica.

Phase 3
Conditions
Health Condition 1: M543- Sciatica
Registration Number
CTRI/2024/05/067332
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having pratyatmalakshana of Gridhrasi

Patients having positive SLR test

Tenderness along the course of sciatic nerve

Exclusion Criteria

1. In secondary Complication- Tuberculosis of the vertebral column.

2. Spinal deformity, spinal tumors, severe traumatic injury, Carcinoma of spine

3. Patient of Gridhrasi involving any structural deformities and needs surgical

care/intervention will excluded.

4. Pregnant women and lactating mothers.

5. Uncontrolled diabetes mellitus, cardiovascular disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Straight leg raise test (in <br/ ><br>degree) <br/ ><br>Timepoint: Baseline, 7th, 14th, 21st and 28th day
Secondary Outcome Measures
NameTimeMethod
To assess the following symptoms along the sciatic nerve route in Mild Moderate & Severe scale <br/ ><br>Pain <br/ ><br>Pricking sensation <br/ ><br>Stiffness <br/ ><br>Twitching <br/ ><br>Timepoint: Baseline, 7th, 14th, 21st & 28th day.
© Copyright 2025. All Rights Reserved by MedPath